Avigen Announces Fourth Quarter 2005 Earnings Conference Call
February 10 2006 - 5:00PM
PR Newswire (US)
ALAMEDA, Calif., Feb. 10 /PRNewswire-FirstCall/ -- Avigen, Inc.
(NASDAQ:AVGN) a biopharmaceutical company developing innovative
therapies for the treatment of neurological conditions announced
that it will be discussing its fourth quarter and full year 2005
results in a conference call at 9:00 am (Eastern time) on Thursday,
February 16th, 2006. Ken Chahine, chief executive officer, and
Michael Coffee, Chief Business Officer, can be heard by dialing
866-713-8562 (tollfree) in the U.S. or +1-617-597-5310 (toll)
elsewhere. Conference ID 19679959 This call is also being webcast
live and can be accessed at Avigen's Web site at
http://www.avigen.com/. For those who cannot listen to the live
broadcast, a replay will be available shortly after the conference
call on the link on the company's website http://www.avigen.com/ or
by dialing 888-286-8010 (tollfree) in the U.S. or +1-617-801-6888
(toll) elsewhere, and entering the access code 60707431. For press
releases and other corporate information, visit our website at
http://www.avigen.com/. DATASOURCE: Avigen, Inc. CONTACT: Michael
Coffee, Chief Business Officer of Avigen, Inc., +1-510-748-7372, or
fax, +1-510-748-7384, or Web site: http://www.avigen.com/
Copyright
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2023 to Jul 2024